Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Per Odin

Showing results (11-20 of 170) with videos related to

Pageof 17
Sort By:
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|April 22, 2009
Continuous dopaminergic stimulation achieved by duodenal levodopa infusionPer Odin, Erik Wolters, Angelo Antonini
Neuropharmacology|March 16, 2022
Non-dopaminergic approaches to the treatment of motor complications in Parkinson's diseaseM Angela Cenci, Katrine Skovgård, Per Odin
Neurology|September 25, 2003
Restless legs syndrome and PD: a review of the evidence for a possible associationDiego Garcia-Borreguero, Per Odin, Carolina Serrano
Pharmacoeconomics|July 7, 2021
Patient Utilities in Health States Based on Hoehn and Yahr and Off-Time in Parkinson's Disease: A Swedish Register-Based Study in 1823 ObservationsJenny M Norlin, Klas Kellerborg, Per Odin
Current Opinion in Neurology|June 9, 2016
Continuous dopaminergic stimulation therapy for Parkinson's disease - recent advancesJonathan Timpka, Ulrika Mundt-Petersen, Per Odin
Movement Disorders Clinical Practice|February 24, 2023
The Relationship between PDQ-8 and Costs in Parkinson's Disease-A Swedish Register-Based StudyKlas Kellerborg, Jenny M Norlin, Per Odin
Acta Neurologica Scandinavica|May 9, 2020
Levodopa infusion in Parkinson's disease: Individual quality of lifeClaas Ehlers, Jonathan Timpka, Per Odin, et al.
International Journal of Clinical Pharmacy|July 20, 2012
Impact of community pharmaceutical care on patient health and quality of drug treatment in Parkinson's diseaseSabrina Schröder, Peter Martus, Per Odin, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|June 21, 2019
Disease stage dependency of motor and non-motor fluctuations in Parkinson's diseaseAlexander Storch, Kristina Rosqvist, Georg Ebersbach, et al.
International Journal of Clinical Pharmacy|June 29, 2011
Drug-related problems in Parkinson's disease: the role of community pharmacists in primary careSabrina Schröder, Peter Martus, Per Odin, et al.
Pageof 17

Showing results (11-20 of 170) with videos related to

Sort By:
Pageof 17
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|April 22, 2009
Continuous dopaminergic stimulation achieved by duodenal levodopa infusionPer Odin, Erik Wolters, Angelo Antonini
Neuropharmacology|March 16, 2022
Non-dopaminergic approaches to the treatment of motor complications in Parkinson's diseaseM Angela Cenci, Katrine Skovgård, Per Odin
Neurology|September 25, 2003
Restless legs syndrome and PD: a review of the evidence for a possible associationDiego Garcia-Borreguero, Per Odin, Carolina Serrano
Pharmacoeconomics|July 7, 2021
Patient Utilities in Health States Based on Hoehn and Yahr and Off-Time in Parkinson's Disease: A Swedish Register-Based Study in 1823 ObservationsJenny M Norlin, Klas Kellerborg, Per Odin
Current Opinion in Neurology|June 9, 2016
Continuous dopaminergic stimulation therapy for Parkinson's disease - recent advancesJonathan Timpka, Ulrika Mundt-Petersen, Per Odin
Movement Disorders Clinical Practice|February 24, 2023
The Relationship between PDQ-8 and Costs in Parkinson's Disease-A Swedish Register-Based StudyKlas Kellerborg, Jenny M Norlin, Per Odin
Acta Neurologica Scandinavica|May 9, 2020
Levodopa infusion in Parkinson's disease: Individual quality of lifeClaas Ehlers, Jonathan Timpka, Per Odin, et al.
International Journal of Clinical Pharmacy|July 20, 2012
Impact of community pharmaceutical care on patient health and quality of drug treatment in Parkinson's diseaseSabrina Schröder, Peter Martus, Per Odin, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|June 21, 2019
Disease stage dependency of motor and non-motor fluctuations in Parkinson's diseaseAlexander Storch, Kristina Rosqvist, Georg Ebersbach, et al.
International Journal of Clinical Pharmacy|June 29, 2011
Drug-related problems in Parkinson's disease: the role of community pharmacists in primary careSabrina Schröder, Peter Martus, Per Odin, et al.
Pageof 17